At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
09637 ALEBUND-B
Trading 08-31 09:41:54
30.660
-0.600
-1.92%
High30.640
Low30.640
Vol100.00
Open30.640
D1 Closing31.260
Amplitude0.00%
Mkt Cap10.67B
Tradable Cap7.24B
Total Shares348.00M
T/O3.06K
T/O Rate0.00%
Tradable Shares236.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Unpacking ALEBUND-B's First Half Results: The Compounding Growth Logic of a Kidney Disease-Focused Biopharma
Hong Kong Stock Alert | ALEBUND-B (09637) Surges Over 6% on Dual Catalysts of Index Inclusion and Earnings, with Mircera Commercialization Poised for Growth
Alebund Pharmaceuticals (Jiangsu) Ltd is a China-based company principally engaged in biopharmaceutical business. The Company’s product portfolio in clinical and preclinical stages consists of one core product AP301 and other product candidates, including one late-clinical-stage product candidate AP306, one early-clinical-stage product candidate (AP303), and four preclinical product candidates (AP308, AP304, AP305, and AP307). The Company mainly operates its businesses in the domestic market and overseas markets.